123 related articles for article (PubMed ID: 32460298)
1. Association between Basal Total Testosterone Levels and Prostate Cancer D'Amico Risk Classes.
Tafuri A; Sebben M; Pirozzi M; Processali T; Shakir A; Rizzetto R; Amigoni N; Brunelli M; Baccaglini W; Migliorini F; Siracusano S; Artibani W; Porcaro AB
Urol Int; 2020; 104(9-10):716-723. PubMed ID: 32460298
[TBL] [Abstract][Full Text] [Related]
2. Endogenous testosterone mirrors prostate cancer aggressiveness: correlation between basal testosterone serum levels and prostate cancer European Urology Association clinical risk classes in a large cohort of Caucasian patients.
Tafuri A; Sebben M; Shakir A; Pirozzi M; Processali T; Rizzetto R; Amigoni N; Brunelli M; Migliorini F; Siracusano S; Cerruto MA; Artibani W; Antonelli A; Porcaro AB
Int Urol Nephrol; 2020 Jul; 52(7):1261-1269. PubMed ID: 32016908
[TBL] [Abstract][Full Text] [Related]
3. Positive Association between Basal Total Testosterone Circulating Levels and Tumor Grade Groups at the Time of Diagnosis of Prostate Cancer.
Porcaro AB; Tafuri A; Sebben M; Pirozzi M; Processali T; Rizzetto R; Amigoni N; Shakir A; Tiso L; Cerrato C; Panunzio A; De Michele M; Cerruto MA; Brunelli M; Migliorini F; Siracusano S; Artibani W
Urol Int; 2019; 103(4):400-407. PubMed ID: 31163438
[TBL] [Abstract][Full Text] [Related]
4. Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical Prostatectomy.
Porcaro AB; Tafuri A; Sebben M; Corsi P; Pocessali T; Pirozzi M; Amigoni N; Rizzetto R; Mariotto A; Inverardi D; Brunelli M; Iacovelli R; Romano M; Siracusano S; Artibani W
Urol Int; 2018; 101(1):38-46. PubMed ID: 29975957
[TBL] [Abstract][Full Text] [Related]
5. Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer.
Porcaro AB; De Luyk N; Corsi P; Sebben M; Tafuri A; Processali T; Cerasuolo M; Mattevi D; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Urol Int; 2017; 99(2):215-221. PubMed ID: 28245478
[TBL] [Abstract][Full Text] [Related]
6. The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy.
Porcaro AB; Caruso B; Terrin A; De Luyk N; Cacciamani G; Corsi P; Inverardi D; De Marchi D; Baldassarre R; Cerruto M; Ghimenton C; Brunelli M; Zecchini Antoniolli S; Petrozziello A; Artibani W
Arch Ital Urol Androl; 2016 Mar; 88(1):17-22. PubMed ID: 27072171
[TBL] [Abstract][Full Text] [Related]
7. Associations of pretreatment serum total testosterone measurements with pathology-detected Gleason score cancer.
Porcaro AB; Petrozziello A; Ghimenton C; Migliorini F; Sava T; Caruso B; Romano M; Cavalleri S; Artibani W
Urol Int; 2014; 93(3):269-78. PubMed ID: 24334919
[TBL] [Abstract][Full Text] [Related]
8. Optimizing D'Amico risk groups in radical prostatectomy through the addition of magnetic resonance imaging data.
Algarra R; Zudaire B; Tienza A; Velis JM; Rincón A; Pascual I; Zudaire J
Actas Urol Esp; 2014 Nov; 38(9):594-9. PubMed ID: 24791621
[TBL] [Abstract][Full Text] [Related]
9. Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy.
Narita S; Mitsuzuka K; Tsuchiya N; Koie T; Kawamura S; Ohyama C; Tochigi T; Yamaguchi T; Arai Y; Habuchi T;
Int J Urol; 2015 Nov; 22(11):1029-35. PubMed ID: 26290306
[TBL] [Abstract][Full Text] [Related]
10. Serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups.
Porcaro AB; Petrozziello A; Ghimenton C; Migliorini F; Sava T; Caruso B; Cocco C; Romano M; Cavalleri S; Artibani W
Urol Int; 2013; 91(1):55-61. PubMed ID: 23751412
[TBL] [Abstract][Full Text] [Related]
11. Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized Medicine.
Capogrosso P; Ventimiglia E; Moschini M; Boeri L; Farina E; Finocchio N; Gandaglia G; Fossati N; Briganti A; Montorsi F; Salonia A
Prostate; 2017 Feb; 77(2):234-241. PubMed ID: 27775173
[TBL] [Abstract][Full Text] [Related]
12. Clinical Factors Associated With Pathological Grade Group 1 Patients in D'Amico Intermediate-Risk Group Following Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group).
Sugino Y; Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kawase M; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
Clin Genitourin Cancer; 2022 Dec; 20(6):593-600. PubMed ID: 35773146
[TBL] [Abstract][Full Text] [Related]
13. Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.
García-Cruz E; Piqueras M; Huguet J; Peri L; Izquierdo L; Musquera M; Franco A; Alvarez-Vijande R; Ribal MJ; Alcaraz A
BJU Int; 2012 Dec; 110(11 Pt B):E541-6. PubMed ID: 22584031
[TBL] [Abstract][Full Text] [Related]
14. Basal total testosterone serum levels predict biopsy and pathological ISUP grade group in a large cohort of Caucasian prostate cancer patients who underwent radical prostatectomy.
Tafuri A; Sebben M; Rizzetto R; Amigoni N; Shakir A; Processali T; Pirozzi M; Gozzo A; Odorizzi K; De Michele M; Gallina S; Bianchi A; Ornaghi PI; Brunelli M; Migliorini F; Cerruto MA; Siracusano S; Artibani W; Antonelli A; Porcaro AB
Ther Adv Urol; 2020; 12():1756287220929481. PubMed ID: 32636934
[TBL] [Abstract][Full Text] [Related]
15. Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.
Porcaro AB; Ghimenton C; Petrozziello A; Sava T; Migliorini F; Romano M; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C
Anticancer Res; 2012 Oct; 32(10):4523-32. PubMed ID: 23060581
[TBL] [Abstract][Full Text] [Related]
16. Beyond D'Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifier.
Gabriele D; Jereczek-Fossa BA; Krengli M; Garibaldi E; Tessa M; Moro G; Girelli G; Gabriele P;
Radiat Oncol; 2016 Feb; 11():23. PubMed ID: 26911291
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook.
Gielchinsky I; Chang J; Cusick T; Delprado W; Nguyen Q; Yuen C; Savdie R; Böhm M; Haynes AM; Scheltema MJ; Stricker PD
BJU Int; 2018 Nov; 122 Suppl 5():35-41. PubMed ID: 30303599
[TBL] [Abstract][Full Text] [Related]
18. A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients.
Leyh-Bannurah SR; Dell'Oglio P; Tian Z; Schiffmann J; Shariat SF; Suardi N; Francesco M; Alberto B; Heinzer H; Huland H; Graefen M; Budäus L; Karakiewicz PI
World J Urol; 2017 Feb; 35(2):189-197. PubMed ID: 27289238
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of Outcomes in D'Amico Intermediate-Risk Prostate Cancer Patients after Radical Prostatectomy: Influence of Primary and Secondary Gleason Score.
Pollard ME; Hobbs AR; Kwon YS; Katsigeorgis M; Lavery HJ; Levinson A; Bernstein AN; Collingwood SA; Hall SJ; Jazayeri SB; Samadi DB
Oncol Res Treat; 2017; 40(9):508-514. PubMed ID: 28796995
[TBL] [Abstract][Full Text] [Related]
20. Total testosterone density predicts high tumor load and disease reclassification of prostate cancer: results in 144 low-risk patients who underwent radical prostatectomy.
Porcaro AB; Tafuri A; Sebben M; Processali T; Pirozzi M; Shakir A; Amigoni N; Rizzetto R; Brunelli M; Migliorini F; Siracusano S; Artibani W
Int Urol Nephrol; 2019 Dec; 51(12):2169-2180. PubMed ID: 31444696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
